1.
Marli M, Pujiastuti W. PRICE EARNING RATIO (PER) DAN NILAI WAJAR SAHAM: EVALUASI KRITIS DALAM INVESTASI (Studi Pada Saham PT Kalbe Farma Tbk, Periode 2019-2023). Dinamika Ekonomi: Jurnal Ekonomi dan Bisnis [Internet]. 31Mar.2025 [cited 15Nov.2025];18(1):92-06. Available from: https://www.stienas-ypb.ac.id/jurnal/index.php/jdeb/article/view/576